Get the Stockscreener App
636.30
2.79%
17.29
After Hours:
636.30
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $636.30, with a volume of 3.20M.
It is up +2.79% in the last 24 hours and up +12.06% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$619.01
Open:
$622.29
24h Volume:
3.20M
Relative Volume:
1.72
Market Cap:
$239.06B
Revenue:
$43.74B
Net Income/Loss:
$6.58B
P/E Ratio:
36.77
EPS:
17.3072
Net Cash Flow:
$6.11B
1W Performance:
+2.33%
1M Performance:
+12.06%
6M Performance:
+57.13%
1Y Performance:
+11.04%
1-Day Range:
$620.27
$637.98
1-Week Range:
$606.00
$637.98
52-Week Range:
$385.46
$637.98
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
636.30 | 232.57B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
242.05 | 165.52B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
696.46 | 54.78B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.40 | 39.80B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.77 | 38.51B | 6.95B | 1.30B | 1.15B | 4.5696 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher’s AI Lab Push And Leadership Shift Might Change The Case For Investing In TMO - simplywall.st
Thermo Fisher Scientific (TMO) Expected to Announce Earnings on Thursday - MarketBeat
Next Generation Sequencing Market Size to Worth USD 103.24 Bn by 2035 - GlobeNewswire Inc.
Thermo Fisher stock hits fresh 52-week high as volume jumps in late trade - TechStock²
Thermo Fisher Scientific (NYSE:TMO) Hits New 12-Month HighWhat's Next? - MarketBeat
P/E Ratio Insights for Thermo Fisher Scientific - Benzinga
Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings - TechStock²
Proteomics Market Dynamics and Contributions by Thermo Fisher - openPR.com
Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus - TechStock²
Biological Safety Cabinet Market with Insights from ESCO, - openPR.com
North America Bioinformatics Market Size, Share, Trends, - openPR.com
Thermo Fisher Scientific introduces DXR3 SmartRaman+ Raman Spectrometer - Select Science
Thermo Fisher stock price holds near $619 after-hours as tariff fears slam Wall Street - TechStock²
Thermo Fisher Scientific and NVIDIA Partner to Advance Laboratory AI Automation - Lab Manager
Peering Into Thermo Fisher Scientific Inc's Recent Short Interest - Benzinga
Thermo Fisher stock slips as Australia opens Clario deal review — what investors watch next - TechStock²
Thermo Fisher's proposal to acquire Clario Holdings to be reviewed in Australia - MLex
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Finviz
Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - GlobeNewswire
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific - Yahoo Finance
Sepsis Treatment Market Is Going to Boom | Thermo Fisher Scientific • Merck & Co. • Pfizer Inc - openPR.com
Thermo Fisher Scientific Inc. (TMO) and NVIDIA partner to bring advanced AI to lab workflows - MSN
Courier Capital LLC Has $3.60 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Allstate Corp Takes $6.67 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Zacks Research Has Positive Forecast for TMO Q4 Earnings - MarketBeat
Thermo Fisher Scientific stock drops before long weekend as TMO traders brace for Jan. 29 earnings - TechStock²
Navera Investment Management Ltd. Has $230.56 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
QRG Capital Management Inc. Reduces Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Rated Second Best Recession Investment, Price Target Raised to $700 - Intellectia AI
Thermo Fisher Scientific Inc. (TMO) and NVIDIA Partner to Bring Advanced AI to Lab Workflows - Insider Monkey
Thermo Fisher stock pulls back from near-$630: what to know before earnings - TechStock²
Is Thermo Fisher Scientific (TMO) Fairly Priced After Recent Life Sciences Demand Headlines - Yahoo Finance
Ritholtz Wealth Management Acquires 1,809 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific (TMO) Valuation After Leadership Shakeup And New AI Lab Partnerships - simplywall.st
Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings - TechStock²
Top Analyst Reports for Visa, AMD & Thermo Fisher - The Globe and Mail
Investing in Thermo Fisher Scientific (NYSE:TMO) Five Years Ago Would Have Delivered You a 24% Gain - 富途资讯
A Weaverville facility produces 'humanity saving' equipment. Why is it closing? - citizen-times.com
Thermo Fisher stock price holds near $625 after-hours as earnings date nears and AI push widens - TechStock²
NVIDIA adds Thermo Fisher to growing roster of healthcare AI partnerships at JPM - R&D World
Nvidia Expands AI Healthcare Push With Lilly, Thermo Fisher - TechRepublic
Thermo Fisher Scientific (NYSE:TMO) Reaches New 52-Week HighTime to Buy? - MarketBeat
Thermo Fisher Scientific stock hits 52-week high at $628.33 - Investing.com
Thermo Fisher Scientific stock hits 52-week high at $628.33 By Investing.com - Investing.com Nigeria
Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts - TechStock²
Precision Carbon Capture Monitoring for Net Zero Goals - AZoM
Thermo Fisher to shut Asheville plant and lay off its 421 workers. Here’s why. - newsobserver.com
Neonatal Toxicology Market Is Going to Boom |• Thermo Fisher Scientific • PerkinElmer - openPR.com
OVERSEA CHINESE BANKING Corp Ltd Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Stephens Inc. AR Has $10.62 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Nordea Investment Management AB Has $82.14 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):